Reduced intensity conditioning with Fludarabine, BCNU and Melphalan (FBM) for allogeneic hematopoietic cell transplantation in elderly AML patients: remission status at transplant predicts outcome

被引：0
|
作者：
Wais, V. [1 ]
Kuendgen, L. [2 ]
Bohl, S. [1 ]
von Harsdorf, S. [1 ]
Schlenk, R. F. [1 ]
Doehner, K. [1 ]
Teleanu, V. [1 ]
Bullinger, L. [1 ]
Drognitz, K. [2 ]
Moulin, J. -C. [2 ]
Binnenhei, M. [2 ]
Bentz, M. [2 ]
Doehner, H. [1 ]
Bunjes, D. [1 ]
Ringhoffer, M. [2 ]
Kuchenbauer, F. [1 ]
机构：
[1] Univ Hosp Ulm, Ulm, Germany
[2] Municipal Hosp Karlsruhe, Karlsruhe, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P616
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [21] Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia
    Chilkulwar, Abhishek
    Sadashiv, Santhosh
    Khan, Cyrus
    Fazal, Salman
    Mewawalla, Prerna
    Kaminsky, Anna
    Berteotti, Gina
    Padhi, Parikshit
    Lister, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S264 - S265
  • [22] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Dominik Schneidawind
    Birgit Federmann
    Corina Buechele
    Andrea Helwig
    Jörg Schmohl
    Wichard Vogel
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Annals of Hematology, 2016, 95 : 115 - 124
  • [23] Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party
    Jesús Duque-Afonso
    Jürgen Finke
    Maud Ngoya
    Jacques-Emmanuel Galimard
    Johannes Schetelig
    Matthias Eder
    Wolf Rösler
    Gesine Bug
    Andreas Neubauer
    Matthias Edinger
    Gerald. G. Wulf
    Pavel Jindra
    Hermann Einsele
    Matthias Stelljes
    Dominik Selleslag
    Eva Maria Wagner-Drouet
    Donald Bunjes
    Alexandros Spyridonidis
    Eolia Brissot
    Arnon Nagler
    Fabio Ciceri
    Mohamad Mohty
    Bone Marrow Transplantation, 2025, 60 (3) : 373 - 379
  • [24] Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia
    Dhere, Vishal
    Edelman, Scott
    Waller, Edmund K.
    Langston, Amelia
    Graiser, Michael
    Connolly, Erin C.
    Switchenko, Jeffrey M.
    Esiashvili, Natia
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 837 - 843
  • [25] Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas
    M Delioukina
    J Zain
    J M Palmer
    N Tsai
    S Thomas
    S Forman
    Bone Marrow Transplantation, 2012, 47 : 65 - 72
  • [26] REDUCED TOXICITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULTS USING FLUDARABINE, BCNU, MELPHALAN, AND ANTITHYMOCYTE GLOBULIN (FBM-A): OUTCOMES DEPEND ON DISEASE RISK INDEX
    Leis, J.
    Dueck, A.
    Fauble, V.
    Sproat, L.
    Noel, P.
    Khera, N.
    Betcher, J.
    Klein, J.
    Adams, R.
    Slack, J.
    HAEMATOLOGICA, 2013, 98 : 158 - 158
  • [27] Reduced-toxicity Conditioning with Fludarabine, Thiotepa and Melphalan in Allogeneic Hematopoietic Cell Transplantation for Patients with Impaired Lung Function
    Duque-Afonso, Jesus
    Ihorst, Gabriele
    Waterhouse, Miguel
    Zeiser, Robert
    Waesch, Ralph
    Bertz, Hartmut
    Yuecel, Mehtap
    Koehler, Thomas
    Mueller-Quernheim, Joachim
    Marks, Reinhard
    Finke, Juergen
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 281 - 282
  • [28] Fludarabine-melphalan as reduced-intensity conditioning for allogeneic stem cell transplantation in AML beyond complete remission: 10-year single centre experience
    Karas, M.
    Steinerova, K.
    Svoboda, T.
    Lysak, D.
    Vokurka, S.
    Vozobulova, V.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S400 - S401
  • [29] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    P Christopoulos
    C Schmoor
    M Waterhouse
    R Marks
    R Wäsch
    H Bertz
    J Finke
    Bone Marrow Transplantation, 2013, 48 : 901 - 907
  • [30] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    Christopoulos, P.
    Schmoor, C.
    Waterhouse, M.
    Marks, R.
    Waesch, R.
    Bertz, H.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 901 - 907
12345